DBV Technologies | Crediti Commerciali



Trade Debtors Cambiamento Data
Acadia Pharmaceuticals USD 113.71M 9.02M 2025-03
Alnylam Pharmaceuticals USD 418.04M 12.73M 2025-03
Amarin USD 112.64M 11.05M 2024-09
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
DBV Technologies USD 20.1M 553K 2024-09
Halozyme Therapeutics USD 304.62M 3.83M 2025-03
Incyte USD 823.13M 30.02M 2025-03
Insmed USD 47.75M 4.27M 2025-03
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
PTC Therapeutics USD 210.5M 51.94M 2025-03
Sarepta Therapeutics USD 724.52M 74.8M 2025-03
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
United Therapeutics USD 322M 42.7M 2025-03



DBV Technologies Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.